Session 6 Drug receptor interactions

    Cards (18)

    • AFFINITY – a measure of the tendency of a drug to bind to a receptor.
    • EFFICACY – a measure of the drug, having once bound to a receptor to activate it.
    • Lower K(D) = higher affinity
      Higher K(D)= lower affinity
    • Affinity + Efficacy = Potency
    • AGONIST – a drug whose efficacy is such that it produces a maximal cell/tissue response when less than 100% of receptors are occupied.
    • PARTIAL AGONIST – a reduced efficacy which means that even when 100% of receptors are occupied, there is only a sub-maximal response generated.
    • Buprenorphine is a partial agonist at opioid receptors.
    • Agonist binding site = Orthosteric binding site
      Other molecule binding site = Allosteric binding site
    • Types of antagonism?
      • Irreversible
      • Chemical
      • Pharmacokinetic
      • Disruption of receptor-response linkage
      • Physiological
    • when the antagonist binds but doesn’t dissociate or dissociates slowly from the receptor - irreversible competitive antagonism
    • combination of substances in solution that results in the loss of effect of a drug – almost chelation - Chemical antagonist
      Example: Infliximab –sequesters TNF and is therefore anti-inflammatory.
    • interference with absorption, metabolism or excretion by one drug on another - pharmacokinetic antagonist.
      Example: Phenytoin influences metabolism of warfarin.
    • DISRUPTION OF RECEPTOR-RESPONSE LINKAGE – downstream inhibition can be described as non-competitive antagonism.Example: Ca2+ channel blockers e.g. nifedipine, non-selectively block smooth muscle contraction induced by all drugs that couple to these channels.
    • PHYSIOLOGICAL – vague definition of the actions of two drugs with opposing action in the body
      Example: Histamine promotes H+ release from parietal cells, omeprazole inhibits this by acting as a PPI.
    • Tolerance - a reduction in response over hours to weeks. Refractoriness - a loss of therapeutic efficacy.
      Resistance - the loss of efficacy of chemotherapeutic agents.
    • Why can't dose-response curves be used to determine the affinity of agonist drug?
      Because responses produced are not always directly proportional to receptor occupancy – maximal response may be produced at <100% occupancy.
    • EC50 abbreviates for 'half maximal effective concentration'. In a pharmacological context, this can be the concentration of a drug that is necessary to cause half of the maximum possible effect.
    • Significance of partial agonists?
      • they generate a response
      • in the presence of a full agonist, they may reduce the response of that full agonist.
    See similar decks